A Nehmé

1.6k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

A Nehmé is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, A Nehmé has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in A Nehmé's work include Genetic factors in colorectal cancer (4 papers), DNA Repair Mechanisms (3 papers) and Retinoids in leukemia and cellular processes (3 papers). A Nehmé is often cited by papers focused on Genetic factors in colorectal cancer (4 papers), DNA Repair Mechanisms (3 papers) and Retinoids in leukemia and cellular processes (3 papers). A Nehmé collaborates with scholars based in United States, France and Norway. A Nehmé's co-authors include R D Christen, S Nebel, Daniel Fink, Stefan Aebi, Bruno Cenni, S B Howell, Hua Zheng, Jeffrey L. Edelman, Stephen B. Howell and Rathinasamy Baskaran and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and Journal of Cellular Physiology.

In The Last Decade

A Nehmé

14 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of DNA mismatch repair in platinum drug resistance.

1996 512 citations Daniel Fink, S Nebel et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Nehmé United States	13	710	643	430	267	109	15	1.3k
Kedar S. Vaidya United States	18	1.1k 1.5×	550 0.9×	259 0.6×	481 1.8×	32 0.3×	35	1.6k
Carla Milagre United Kingdom	6	1.1k 1.6×	712 1.1×	204 0.5×	140 0.5×	32 0.3×	8	1.4k
Tom Truong United States	8	709 1.0×	393 0.6×	93 0.2×	231 0.9×	46 0.4×	12	1.0k
S Ritland United States	12	444 0.6×	235 0.4×	228 0.5×	245 0.9×	67 0.6×	22	965
Samuel Seoane Spain	18	492 0.7×	361 0.6×	153 0.4×	183 0.7×	73 0.7×	38	1.1k
Kevin P. Rice United States	8	707 1.0×	605 0.9×	81 0.2×	170 0.6×	48 0.4×	10	1.1k
Steven A. Enkemann United States	18	783 1.1×	414 0.6×	110 0.3×	246 0.9×	65 0.6×	31	1.3k
Esther Castellano Spain	16	1.3k 1.8×	458 0.7×	134 0.3×	243 0.9×	76 0.7×	20	1.7k
Louis Hornez France	17	784 1.1×	407 0.6×	203 0.5×	205 0.8×	41 0.4×	41	1.4k
Laurie M. Strawn United States	9	899 1.3×	394 0.6×	87 0.2×	369 1.4×	29 0.3×	12	1.2k

Countries citing papers authored by A Nehmé

Since Specialization

Citations

This map shows the geographic impact of A Nehmé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Nehmé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Nehmé more than expected).

Fields of papers citing papers by A Nehmé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Nehmé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Nehmé. The network helps show where A Nehmé may publish in the future.

Co-authorship network of co-authors of A Nehmé

This figure shows the co-authorship network connecting the top 25 collaborators of A Nehmé. A scholar is included among the top collaborators of A Nehmé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Nehmé. A Nehmé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Nehmé, A, et al.. (2021). P.087 Successful response to rituximab in a patient with Aβ related angiitis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48(s3). S44–S44.

Nehmé, A, Edward K. Lobenhofer, W. Daniel Stamer, & Jeffrey L. Edelman. (2009). Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells. BMC Medical Genomics. 2(1). 58–58. 82 indexed citations

Nehmé, A & Jeffrey L. Edelman. (2008). Dexamethasone Inhibits High Glucose–, TNF-α–, and IL-1β–Induced Secretion of Inflammatory and Angiogenic Mediators from Retinal Microvascular Pericytes. Investigative Ophthalmology & Visual Science. 49(5). 2030–2030. 71 indexed citations

Cenni, Bruno, Stefan Aebi, A Nehmé, & R D Christen. (2001). Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway. Cancer Chemotherapy and Pharmacology. 47(5). 397–403. 15 indexed citations

Nehmé, A, et al.. (2001). Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells. British Journal of Cancer. 84(11). 1571–1576. 74 indexed citations

Nehmé, A, et al.. (2000). Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage. British Journal of Cancer. 83(10). 1360–1366. 2 indexed citations

Nehmé, A, Rathinasamy Baskaran, S Nebel, et al.. (1999). Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. British Journal of Cancer. 79(7-8). 1104–1110. 87 indexed citations

Lafon, Corinne, Isabelle Lochon, A Nehmé, et al.. (1997). Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines. British Journal of Cancer. 75(3). 333–340. 29 indexed citations

Fink, Daniel, Hongtu Zheng, S Nebel, et al.. (1997). In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.. PubMed. 57(10). 1841–5. 232 indexed citations

10.

Fink, Daniel, S Nebel, Stefan Aebi, A Nehmé, & Stephen B. Howell. (1997). Loss of DNA mismatch repair due to knockout of MSH2 or PMS2 results in resistance to cisplatin and carboplatin. International Journal of Oncology. 11(3). 539–42. 26 indexed citations

11.

Nehmé, A, Rathinasamy Baskaran, Stefan Aebi, et al.. (1997). Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin.. PubMed. 57(15). 3253–7. 110 indexed citations

12.

Fink, Daniel, S Nebel, Stefan Aebi, et al.. (1996). The role of DNA mismatch repair in platinum drug resistance.. PubMed. 56(21). 4881–6. 512 indexed citations breakdown →

13.

Nehmé, A, Nicolas Albin, Sylvie M. Guichard, et al.. (1995). Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian‐cancer cell lines. International Journal of Cancer. 61(5). 643–648. 12 indexed citations

14.

Starzec, Anna, Emmanuel Spanakis, A Nehmé, et al.. (1994). Proliferative responses of epithelial cells to 8‐bromo‐cyclic AMP and to a phorbol ester change during breast Pathogenesis. Journal of Cellular Physiology. 161(1). 31–38. 25 indexed citations

15.

Nehmé, A, et al.. (1994). Modulation of cisplatin cytotoxicity by human recombinant interferon-γ in human ovarian cancer cell lines. European Journal of Cancer. 30(4). 520–525. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact